UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease

Clinics in liver disease, 2016-11, Vol.20 (4), p.607

2016

Volltextzugriff (PDF)

Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic

American journal of preventive medicine, 2021-09, Vol.61 (3), p.369-376

2021

Volltextzugriff (PDF)

Outcomes of infants born to women infected with hepatitis B

Pediatrics (Evanston), 2015-05, Vol.135 (5), p.e1141

2015

Volltextzugriff (PDF)

Hepatitis C Treatment Among Commercially or Medicaid-Insured Individuals, 2014–2018

American journal of preventive medicine, 2021-11, Vol.61 (5), p.716-723

2021

Volltextzugriff (PDF)

Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children

American journal of preventive medicine, 2018-11, Vol.55 (5), p.633-641

2018

Volltextzugriff (PDF)

Evaluation of epidemic intelligence systems integrated in the early alerting and reporting project for the detection of A/H5N1 influenza events

PloS one, 2013-03, Vol.8 (3), p.e57252-e57252

2013

Volltextzugriff (PDF)

Trends and Opportunities: Hepatitis A Virus Infection, Seroprevalence, and Vaccination Coverage—United States, 1976-2020

Public health reports (1974), 2023-07, p.333549231184007

2023

Volltextzugriff (PDF)

Development of a Standardized, Laboratory Result–Based Hepatitis C Virus Clearance Cascade for Public Health Jurisdictions

Public health reports (1974), 2024-03, Vol.139 (2), p.149-153

2024

Volltextzugriff (PDF)

Factors influencing performance of internet-based biosurveillance systems used in epidemic intelligence for early detection of infectious diseases outbreaks

PloS one, 2014-03, Vol.9 (3), p.e90536-e90536

2014

Volltextzugriff (PDF)

Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska

Journal of medical virology, 2021-06, Vol.93 (6), p.3991-3994

2021

Volltextzugriff (PDF)

Assessing the Cost-Utility of Universal Hepatitis B Vaccination Among Adults

The Journal of infectious diseases, 2022-09, Vol.226 (6), p.1041-1051

2022

Volltextzugriff (PDF)

Missed opportunities for prevention and treatment of hepatitis C among persons with HIV/HCV coinfection

AIDS care, 2020-07, Vol.32 (7), p.921-929

2020

Volltextzugriff (PDF)

Corrigendum to “Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations” [Vaccine 38(51) (2020) 8206–8215]

Vaccine, 2021-08, Vol.39 (36), p.5231-5231

2021

Volltextzugriff (PDF)

Update on Hepatitis A Management

JAMA : the journal of the American Medical Association, 2021-01, Vol.325 (4), p.401

2021

Volltextzugriff (PDF)

The Hepatitis B Care Cascade Using Administrative Claims Data, 2016

The American journal of managed care, 2020-08, Vol.26 (8), p.331-338

2020

Volltextzugriff (PDF)

Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015–2020

American journal of preventive medicine, 2023-07, Vol.65 (1), p.52-59

2023

Volltextzugriff (PDF)

Prevention of Perinatal Hepatitis B Virus Transmission

Journal of the Pediatric Infectious Diseases Society, 2014-09, Vol.3 (suppl_1), p.S7-S12

2014

Volltextzugriff (PDF)

Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019

Medical care, 2023-04, Vol.61 (4), p.247

2023

Volltextzugriff (PDF)

Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022

American journal of transplantation, 2022-06, Vol.22 (6), p.1714-1720

2022

Volltextzugriff (PDF)

Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016

Vaccine, 2018-03, Vol.36 (12), p.1650-1659

2018

Volltextzugriff (PDF)

Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection—Alaska, 1996–2018

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2212-2214

2021

Volltextzugriff (PDF)

Estimated Additional Number of Adults in HIV Care Who Have an Indication for Hepatitis A Vaccination Following 2020 US Guideline Update

Journal of acquired immune deficiency syndromes (1999), 2020-10, Vol.85 (2), p.e29

2020

Volltextzugriff (PDF)

Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus

Gastroenterology (New York, N.Y. 1943), 2018-06, Vol.154 (8), p.2015-2017

2018

Volltextzugriff (PDF)

Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015

Vaccine, 2018-01, Vol.36 (4), p.559-564

2018

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaInfections

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(99)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(56)
Humans
(45)
Adult
(23)
Public, Environmental & Occupational Health
(22)
Female
(21)
Hepatitis
(19)
Vaccination
(17)
Hepatitis B
(16)
Vaccines
(14)
Infectious Diseases
(13)
Middle Aged
(13)
Hepatitis A
(12)
Immunization
(12)
Male
(12)
Public Health
(11)
United States
(11)
Hepatitis A - Prevention & Control
(10)
Immunology
(10)
Pregnancy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease

Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic

Outcomes of infants born to women infected with hepatitis B

Hepatitis C Treatment Among Commercially or Medicaid-Insured Individuals, 2014–2018

Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study

Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children

Evaluation of epidemic intelligence systems integrated in the early alerting and reporting project for the detection of A/H5N1 influenza events

Trends and Opportunities: Hepatitis A Virus Infection, Seroprevalence, and Vaccination Coverage—United States, 1976-2020

Development of a Standardized, Laboratory Result–Based Hepatitis C Virus Clearance Cascade for Public Health Jurisdictions

Factors influencing performance of internet-based biosurveillance systems used in epidemic intelligence for early detection of infectious diseases outbreaks

Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska

Assessing the Cost-Utility of Universal Hepatitis B Vaccination Among Adults

Missed opportunities for prevention and treatment of hepatitis C among persons with HIV/HCV coinfection

Corrigendum to “Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations” [Vaccine 38(51) (2020) 8206–8215]

Update on Hepatitis A Management

The Hepatitis B Care Cascade Using Administrative Claims Data, 2016

Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015–2020

Prevention of Perinatal Hepatitis B Virus Transmission

Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019

Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022

Hepatitis A vaccination coverage among adolescents (13–17 years) in the United States, 2008–2016

Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection—Alaska, 1996–2018

Estimated Additional Number of Adults in HIV Care Who Have an Indication for Hepatitis A Vaccination Following 2020 US Guideline Update

Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus

Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015

Aktive Filter

Suchergebnisse filtern